CareStart™ CAH
Send a free RFQ and get the supplier's best price.
Trade with confidence on Abraa
Safe and secure payments using Abraa safe trade systems
Supplier verification not completed
Pay only through Abraa to stay protected. Never pay a supplier by direct transfer.
Secure Payment
Pay through Abraa, never by direct transfer to a supplier.
Product Inspection
Book a check before shipping to confirm quality and quantity.
Buyer Protection
Get support and refunds if goods arrive not as described.
Verified Suppliers
Licence, address and on-site checks by the Abraa team.
Product Specification
| Brand | Access Bio |
| Condition | New |
Product Descriptions
Congenital Adrenal Hyperplasia (CAH) is a genetic disorder that limits adrenal glands’ ability to produce certain vital hormones, causing altered development of primary or secondary sex characteristics in affected infants and children, or adults. It can be fully treated when detected early through newborn screening with high sensitive molecular diagnostic tests.Features & Benefits
- Screening for congenital adrenal hyperplasia (CAH) mutations on CYP21, using allele-specific primer extension (ASPE) and bead-array hybridization.
- Detection of the 10 major point mutations and the 8 bp deletion at Chromosome 6p21.3
- Detection of a large deletion between CYP21A1p and CYP21A2
- Semi-quantitative test with bead array for point mutation and agarose electrophoresis for a large deletion
- Approximately 8hours from DNA extraction to data reporting.
\